Sarepta Therapeutics Inc [NASDAQ: SRPT] stock went on an upward path that rose over 3.57% on Tuesday, amounting to a one-week price decrease of less than -6.69%.
Over the last 12 months, SRPT stock dropped by -85.43%. The one-year Sarepta Therapeutics Inc stock forecast points to a potential downside of -10185085.19. The average equity rating for SRPT stock is currently 2.07, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $1.74 billion, with 98.25 million shares outstanding and 93.47 million shares in the current float. Compared to the average trading volume of 5.28M shares, SRPT stock reached a trading volume of 6176679 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Sarepta Therapeutics Inc [SRPT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SRPT shares is $51.84 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SRPT stock is a recommendation set at 2.07. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Sarepta Therapeutics Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on June 20, 2025. The new note on the price target was released on June 18, 2025, representing the official price target for Sarepta Therapeutics Inc stock.
The Price to Book ratio for the last quarter was 1.52, with the Price to Cash per share for the same quarter was set at 5.32.
SRPT Stock Performance Analysis:
Sarepta Therapeutics Inc [SRPT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.69. With this latest performance, SRPT shares dropped by -52.90% in over the last four-week period, additionally sinking by -85.64% over the last 6 months – not to mention a drop of -85.43% in the past year of trading.
Insight into Sarepta Therapeutics Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Sarepta Therapeutics Inc [SRPT] shares currently have an operating margin of -5.25% and a Gross Margin at 80.07%. Sarepta Therapeutics Inc’s Net Margin is presently recorded at -11.12%.
Return on Equity for this stock declined to -7.43%, with Return on Assets sitting at -7.43%.
SRPT Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SRPT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sarepta Therapeutics Inc go to 19.75%.
Sarepta Therapeutics Inc [SRPT] Institutonal Ownership Details
There are presently around $96.33%, or 100.78%% of SRPT stock, in the hands of institutional investors. The top three institutional holders of SRPT stocks are: BLACKROCK INC. with ownership of 10.32 million shares, which is approximately 10.9117%. VANGUARD GROUP INC, holding 9.04 million shares of the stock with an approximate value of $$1.43 billion in SRPT stocks shares; and VANGUARD GROUP INC, currently with $$682.69 million in SRPT stock with ownership which is approximately 4.5666%.
